Global First-in-Human (FIH) Services Market growth is projected to reach USD $ Billion in 2025, at a $% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2025 to 2031.

Global First-in-Human (FIH) Services Market Trends and Outlook 2025-31

The global First-in-Human (FIH) Services market size is predicted to grow from US$ 667 million in 2025 to US$ 1299 million in 2031; it is expected to grow at a CAGR of 11.7% from 2025 to 2031. First-in-Human Services refer to specialized services that support the planning, execution, and management of First-in-Human (FIH) clinical trials. These services are critical for the successful transition of a drug or therapeutic product from preclinical development to initial testing in human subjects. FIH trials are typically the first time a new drug is administered to humans, making the associated services essential for ensuring safety, compliance, and scientific validity.First-in-Human Services are essential for minimizing risks associated with the early testing of new drugs in humans, ensuring regulatory compliance, and generating reliable data that can influence subsequent phases of drug development. These services help streamline the clinical trial process, improve efficiency, and enhance the likelihood of successful product development. United States market for First-in-Human (FIH) Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for First-in-Human (FIH) Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for First-in-Human (FIH) Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key First-in-Human (FIH) Services players cover WuXi AppTec, Allucent, Altasciences, LAXAI, Lonza, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LPI (LP Information) newest research report, the ?First-in-Human (FIH) Services Industry Forecast? looks at past sales and reviews total world First-in-Human (FIH) Services sales in 2024, providing a comprehensive analysis by region and market sector of projected First-in-Human (FIH) Services sales for 2025 through 2031. With First-in-Human (FIH) Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world First-in-Human (FIH) Services industry. This Insight Report provides a comprehensive analysis of the global First-in-Human (FIH) Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on First-in-Human (FIH) Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global First-in-Human (FIH) Services market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for First-in-Human (FIH) Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global First-in-Human (FIH) Services. This report presents a comprehensive overview, market shares, and growth opportunities of First-in-Human (FIH) Services market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Drugs &nbsp;&nbsp;&nbsp; Medical Device Segmentation by Application: &nbsp;&nbsp;&nbsp; Pharmaceutical Companies &nbsp;&nbsp;&nbsp; Contract Research Organizations (CROs) &nbsp;&nbsp;&nbsp; Academic Institutions and Research Centers &nbsp;&nbsp;&nbsp; Medical Device Companies This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; WuXi AppTec &nbsp;&nbsp;&nbsp; Allucent &nbsp;&nbsp;&nbsp; Altasciences &nbsp;&nbsp;&nbsp; LAXAI &nbsp;&nbsp;&nbsp; Lonza &nbsp;&nbsp;&nbsp; Syneos Health &nbsp;&nbsp;&nbsp; CD BioSciences &nbsp;&nbsp;&nbsp; Fortrea &nbsp;&nbsp;&nbsp; Certara &nbsp;&nbsp;&nbsp; Evotec &nbsp;&nbsp;&nbsp; Aixial Group &nbsp;&nbsp;&nbsp; Quotient Sciences &nbsp;&nbsp;&nbsp; Sofpromed &nbsp;&nbsp;&nbsp; Spaulding Clinical &nbsp;&nbsp;&nbsp; Biotrial &nbsp;&nbsp;&nbsp; Crystal Pharmatech Co., Ltd &nbsp;&nbsp;&nbsp; Avania

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global First-in-Human (FIH) Services Market Size (2020-2031) &nbsp;2.1.2 First-in-Human (FIH) Services Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for First-in-Human (FIH) Services by Country/Region (2020, 2024 & 2031) &nbsp;2.2 First-in-Human (FIH) Services Segment by Type &nbsp;2.2.1 Drugs &nbsp;2.2.2 Medical Device &nbsp;2.3 First-in-Human (FIH) Services Market Size by Type &nbsp;2.3.1 First-in-Human (FIH) Services Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global First-in-Human (FIH) Services Market Size Market Share by Type (2020-2025) &nbsp;2.4 First-in-Human (FIH) Services Segment by Application &nbsp;2.4.1 Pharmaceutical Companies &nbsp;2.4.2 Contract Research Organizations (CROs) &nbsp;2.4.3 Academic Institutions and Research Centers &nbsp;2.4.4 Medical Device Companies &nbsp;2.5 First-in-Human (FIH) Services Market Size by Application &nbsp;2.5.1 First-in-Human (FIH) Services Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global First-in-Human (FIH) Services Market Size Market Share by Application (2020-2025) 3 First-in-Human (FIH) Services Market Size by Player &nbsp;3.1 First-in-Human (FIH) Services Market Size Market Share by Player &nbsp;3.1.1 Global First-in-Human (FIH) Services Revenue by Player (2020-2025) &nbsp;3.1.2 Global First-in-Human (FIH) Services Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global First-in-Human (FIH) Services Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 First-in-Human (FIH) Services by Region &nbsp;4.1 First-in-Human (FIH) Services Market Size by Region (2020-2025) &nbsp;4.2 Global First-in-Human (FIH) Services Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas First-in-Human (FIH) Services Market Size Growth (2020-2025) &nbsp;4.4 APAC First-in-Human (FIH) Services Market Size Growth (2020-2025) &nbsp;4.5 Europe First-in-Human (FIH) Services Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa First-in-Human (FIH) Services Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas First-in-Human (FIH) Services Market Size by Country (2020-2025) &nbsp;5.2 Americas First-in-Human (FIH) Services Market Size by Type (2020-2025) &nbsp;5.3 Americas First-in-Human (FIH) Services Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC First-in-Human (FIH) Services Market Size by Region (2020-2025) &nbsp;6.2 APAC First-in-Human (FIH) Services Market Size by Type (2020-2025) &nbsp;6.3 APAC First-in-Human (FIH) Services Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe First-in-Human (FIH) Services Market Size by Country (2020-2025) &nbsp;7.2 Europe First-in-Human (FIH) Services Market Size by Type (2020-2025) &nbsp;7.3 Europe First-in-Human (FIH) Services Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa First-in-Human (FIH) Services by Region (2020-2025) &nbsp;8.2 Middle East & Africa First-in-Human (FIH) Services Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa First-in-Human (FIH) Services Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global First-in-Human (FIH) Services Market Forecast &nbsp;10.1 Global First-in-Human (FIH) Services Forecast by Region (2026-2031) &nbsp;10.1.1 Global First-in-Human (FIH) Services Forecast by Region (2026-2031) &nbsp;10.1.2 Americas First-in-Human (FIH) Services Forecast &nbsp;10.1.3 APAC First-in-Human (FIH) Services Forecast &nbsp;10.1.4 Europe First-in-Human (FIH) Services Forecast &nbsp;10.1.5 Middle East & Africa First-in-Human (FIH) Services Forecast &nbsp;10.2 Americas First-in-Human (FIH) Services Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market First-in-Human (FIH) Services Forecast &nbsp;10.2.2 Canada Market First-in-Human (FIH) Services Forecast &nbsp;10.2.3 Mexico Market First-in-Human (FIH) Services Forecast &nbsp;10.2.4 Brazil Market First-in-Human (FIH) Services Forecast &nbsp;10.3 APAC First-in-Human (FIH) Services Forecast by Region (2026-2031) &nbsp;10.3.1 China First-in-Human (FIH) Services Market Forecast &nbsp;10.3.2 Japan Market First-in-Human (FIH) Services Forecast &nbsp;10.3.3 Korea Market First-in-Human (FIH) Services Forecast &nbsp;10.3.4 Southeast Asia Market First-in-Human (FIH) Services Forecast &nbsp;10.3.5 India Market First-in-Human (FIH) Services Forecast &nbsp;10.3.6 Australia Market First-in-Human (FIH) Services Forecast &nbsp;10.4 Europe First-in-Human (FIH) Services Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market First-in-Human (FIH) Services Forecast &nbsp;10.4.2 France Market First-in-Human (FIH) Services Forecast &nbsp;10.4.3 UK Market First-in-Human (FIH) Services Forecast &nbsp;10.4.4 Italy Market First-in-Human (FIH) Services Forecast &nbsp;10.4.5 Russia Market First-in-Human (FIH) Services Forecast &nbsp;10.5 Middle East & Africa First-in-Human (FIH) Services Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market First-in-Human (FIH) Services Forecast &nbsp;10.5.2 South Africa Market First-in-Human (FIH) Services Forecast &nbsp;10.5.3 Israel Market First-in-Human (FIH) Services Forecast &nbsp;10.5.4 Turkey Market First-in-Human (FIH) Services Forecast &nbsp;10.6 Global First-in-Human (FIH) Services Forecast by Type (2026-2031) &nbsp;10.7 Global First-in-Human (FIH) Services Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market First-in-Human (FIH) Services Forecast 11 Key Players Analysis &nbsp;11.1 WuXi AppTec &nbsp;11.1.1 WuXi AppTec Company Information &nbsp;11.1.2 WuXi AppTec First-in-Human (FIH) Services Product Offered &nbsp;11.1.3 WuXi AppTec First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 WuXi AppTec Main Business Overview &nbsp;11.1.5 WuXi AppTec Latest Developments &nbsp;11.2 Allucent &nbsp;11.2.1 Allucent Company Information &nbsp;11.2.2 Allucent First-in-Human (FIH) Services Product Offered &nbsp;11.2.3 Allucent First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Allucent Main Business Overview &nbsp;11.2.5 Allucent Latest Developments &nbsp;11.3 Altasciences &nbsp;11.3.1 Altasciences Company Information &nbsp;11.3.2 Altasciences First-in-Human (FIH) Services Product Offered &nbsp;11.3.3 Altasciences First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Altasciences Main Business Overview &nbsp;11.3.5 Altasciences Latest Developments &nbsp;11.4 LAXAI &nbsp;11.4.1 LAXAI Company Information &nbsp;11.4.2 LAXAI First-in-Human (FIH) Services Product Offered &nbsp;11.4.3 LAXAI First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 LAXAI Main Business Overview &nbsp;11.4.5 LAXAI Latest Developments &nbsp;11.5 Lonza &nbsp;11.5.1 Lonza Company Information &nbsp;11.5.2 Lonza First-in-Human (FIH) Services Product Offered &nbsp;11.5.3 Lonza First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Lonza Main Business Overview &nbsp;11.5.5 Lonza Latest Developments &nbsp;11.6 Syneos Health &nbsp;11.6.1 Syneos Health Company Information &nbsp;11.6.2 Syneos Health First-in-Human (FIH) Services Product Offered &nbsp;11.6.3 Syneos Health First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Syneos Health Main Business Overview &nbsp;11.6.5 Syneos Health Latest Developments &nbsp;11.7 CD BioSciences &nbsp;11.7.1 CD BioSciences Company Information &nbsp;11.7.2 CD BioSciences First-in-Human (FIH) Services Product Offered &nbsp;11.7.3 CD BioSciences First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 CD BioSciences Main Business Overview &nbsp;11.7.5 CD BioSciences Latest Developments &nbsp;11.8 Fortrea &nbsp;11.8.1 Fortrea Company Information &nbsp;11.8.2 Fortrea First-in-Human (FIH) Services Product Offered &nbsp;11.8.3 Fortrea First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Fortrea Main Business Overview &nbsp;11.8.5 Fortrea Latest Developments &nbsp;11.9 Certara &nbsp;11.9.1 Certara Company Information &nbsp;11.9.2 Certara First-in-Human (FIH) Services Product Offered &nbsp;11.9.3 Certara First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Certara Main Business Overview &nbsp;11.9.5 Certara Latest Developments &nbsp;11.10 Evotec &nbsp;11.10.1 Evotec Company Information &nbsp;11.10.2 Evotec First-in-Human (FIH) Services Product Offered &nbsp;11.10.3 Evotec First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Evotec Main Business Overview &nbsp;11.10.5 Evotec Latest Developments &nbsp;11.11 Aixial Group &nbsp;11.11.1 Aixial Group Company Information &nbsp;11.11.2 Aixial Group First-in-Human (FIH) Services Product Offered &nbsp;11.11.3 Aixial Group First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Aixial Group Main Business Overview &nbsp;11.11.5 Aixial Group Latest Developments &nbsp;11.12 Quotient Sciences &nbsp;11.12.1 Quotient Sciences Company Information &nbsp;11.12.2 Quotient Sciences First-in-Human (FIH) Services Product Offered &nbsp;11.12.3 Quotient Sciences First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Quotient Sciences Main Business Overview &nbsp;11.12.5 Quotient Sciences Latest Developments &nbsp;11.13 Sofpromed &nbsp;11.13.1 Sofpromed Company Information &nbsp;11.13.2 Sofpromed First-in-Human (FIH) Services Product Offered &nbsp;11.13.3 Sofpromed First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Sofpromed Main Business Overview &nbsp;11.13.5 Sofpromed Latest Developments &nbsp;11.14 Spaulding Clinical &nbsp;11.14.1 Spaulding Clinical Company Information &nbsp;11.14.2 Spaulding Clinical First-in-Human (FIH) Services Product Offered &nbsp;11.14.3 Spaulding Clinical First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Spaulding Clinical Main Business Overview &nbsp;11.14.5 Spaulding Clinical Latest Developments &nbsp;11.15 Biotrial &nbsp;11.15.1 Biotrial Company Information &nbsp;11.15.2 Biotrial First-in-Human (FIH) Services Product Offered &nbsp;11.15.3 Biotrial First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 Biotrial Main Business Overview &nbsp;11.15.5 Biotrial Latest Developments &nbsp;11.16 Crystal Pharmatech Co., Ltd &nbsp;11.16.1 Crystal Pharmatech Co., Ltd Company Information &nbsp;11.16.2 Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Product Offered &nbsp;11.16.3 Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 Crystal Pharmatech Co., Ltd Main Business Overview &nbsp;11.16.5 Crystal Pharmatech Co., Ltd Latest Developments &nbsp;11.17 Avania &nbsp;11.17.1 Avania Company Information &nbsp;11.17.2 Avania First-in-Human (FIH) Services Product Offered &nbsp;11.17.3 Avania First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.17.4 Avania Main Business Overview &nbsp;11.17.5 Avania Latest Developments 12 Research Findings and Conclusion

Report	Global First-in-Human (FIH) Services Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI8606

Buyer Information

Order Summary